Market Prices

BTC Bitcoin
$64,088.2 +1.38%
ETH Ethereum
$1,843.97 +1.27%
SOL Solana
$74.91 +0.77%
BNB BNB Chain
$570.1 +1.53%
XRP XRP Ledger
$1.09 +0.83%
DOGE Dogecoin
$0.0722 +0.43%
ADA Cardano
$0.1645 +1.42%
AVAX Avalanche
$6.56 +1.75%
DOT Polkadot
$0.8325 -1.51%
LINK Chainlink
$8.27 +1.83%

Event Calendar

{{年份}}
08
04
upgrade Solana Firedancer

Independent validator client goes live on mainnet

15
04
halving Bitcoin Halving

Block reward reduced to 3.125 BTC

12
05
halving BCH Halving

Block reward halving event

10
05
upgrade Ethereum Pectra Upgrade

Raises validator limit and account abstraction

30
04
upgrade Celestia Mainnet Upgrade

Improves data availability sampling efficiency

22
03
unlock Optimism Unlock

Circulating supply increases by about 2%

18
03
unlock Sui Token Unlock

Team and early investor shares released

28
03
unlock Arbitrum Token Unlock

92 million ARB released

Gas Tracker

Ethereum 28 Gwei
BNB Chain 3 Gwei
Polygon 42 Gwei
Arbitrum 0.5 Gwei
Optimism 0.3 Gwei

💡 Smart Money

0x652c...f7f3
Top DeFi Miner
+$2.8M
90%
0xd9f3...1252
Market Maker
+$2.4M
90%
0xc58c...120e
Top DeFi Miner
+$4.9M
66%

🧮 Tools

All →

Chemistry Ventures' $500M Bet on Fintech Over Crypto: The Capital Shift Nobody Wants to Talk About

CryptoFox
Guide
The tape doesn't lie. Chemistry Ventures just closed a $500 million second fund. The kicker? They're not throwing a penny at crypto. The press release screams 'fintech.' The partners smile for the cameras. But the subtext is deafening: traditional capital is voting with its dollars, and crypto is losing the ballot. I've been watching VC flows for seven years now, through ICO mania, DeFi summer, the NFT carnival, and the FTX hangover. This isn't a blip. It's a tectonic readjustment. And most analysts are missing the real story. Let me paint the context. We're in a bull market for Bitcoin—ETF inflows are solid, retail is creeping back. But the money that builds the next generation of protocols—the venture capital that funds smart contract audits, SDK development, and liquidity bootstrapping—is drying up. Chemistry Ventures is the latest proof. Their first fund, raised in 2021, had a healthy allocation to crypto infrastructure. This time? Zero. The fund's managing partner explicitly stated that 'the risk-adjusted return profile of fintech offers more stability.' That's polite VC-speak for 'crypto is too volatile and too regulatory messy.' We didn't need a memo to know that, but here it is, signed and funded. The core facts are simple. Chemistry Ventures raised $500 million from institutional LPs—pension funds, endowments, insurance companies. Those LPs could have demanded exposure to DeFi yields or Bitcoin mining. They didn't. They chose traditional fintech: payment rails, lending platforms, banking-as-a-service APIs. The immediate impact on crypto markets is subtle but real. Early-stage projects that rely on VC checks to survive will face a starker funding winter. I've seen this play out before. In 2022, when Paradigm and a16z pulled back, the signal was clear. Now it's not just crypto-native VCs tightening belts; it's the entire capital ecosystem repricing risk. The market response has been muted—a slight dip in Ethereum gas fees, a quiet shuffle in NFT floor prices. But the underlying current is strong. The tape doesn't lie: volume on token sale platforms is down 40% year-over-year. We didn't need a blockchain explorer to spot that trend. Now for the contrarian angle that nobody wants to talk about. This isn't a simple story of 'crypto bad, fintech good.' It's a story about crypto's failure to capture institutional trust at the product level. I've audited projects that raised $50 million on a whitepaper and delivered a website. I've seen DAOs with treasuries larger than some small countries spend 90% of their capital on marketing and 10% on engineering. The technology is revolutionary, but the execution is often amateur. Chemistry Ventures' move is a rational response to a market that has punished naive capital allocation. But here's the twist: this could actually be good for crypto in the long run. When rich, lazy money stops flowing, only builders who truly understand the technology survive. The 2017 ICO crash gave us Ethereum's DeFi summer. The 2022 venture pullback gave us Bitcoin L2s and real-world asset tokenization that actually works. The current shift might force founders to build revenue-generating products instead of token-dependent casinos. I've seen it happen before—in the DeFi crash of 2020, when I wrote 'Farming with Friends,' the projects that survived were the ones with actual product-market fit, not just liquidity mining contracts. We didn't need a crystal ball to see that then. We don't need one now. Let me drill into the technical implications. This VC pivot means that for the next 12-18 months, crypto startups will have two choices: bootstrap or die. Bootstrapping means reducing reliance on token inflation, building real user bases, and charging fees that cover costs. It means auditing contracts with funds from revenue, not VC grants. I've seen it work. Uniswap didn't raise a $100 million Series A. It built a protocol that people used and then captured value. Compound didn't need a massive treasury to survive the bear. They had a product that lenders and borrowers relied on. The projects that will thrive are the ones that treat their protocol as a business, not a narrative. The contrarian truth is that Chemistry Ventures' fund is a gift to disciplined builders. It filters out the noise. The capital that remains will be smarter, more patient, and more demanding. The tape doesn't lie: the best time to build infrastructure is when everyone else is distracted by shiny consumer apps. Now, I want to address the social sentiment. The crypto community is already reacting with a mix of denial and anger. I've scrolled through Telegram groups and Discord channels. 'Fintech is boring,' they say. 'VCs don't understand innovation.' That's coping mechanism, not analysis. The reality is that traditional capital has watched crypto's regulatory chaos from the sidelines. They've seen token projects collapse under legal pressure. They've seen founders disappear with millions. They want the innovation without the liability. That's why Chemistry Ventures is betting on fintech—it's a sector with clear rules, existing customer relationships, and proven revenue models. The sentiment among retail traders is still bullish on Bitcoin, but the sentiment among capital allocators is cautious. I saw the same disconnect in 2021 before the crash. We didn't learn the lesson then. Will we learn it now? Let me give you a specific case from my experience. I've been tracking a project that raised $5 million from a top-tier crypto fund in 2022. They built a cross-chain bridge with innovative security features. But when I audited their tokenomics earlier this year, I found that 70% of the supply was allocated to investors and team, with a 12-month cliff. The project had zero revenue. The only way to sustain the price was a continuous stream of new buyers—exactly the kind of Ponzinomics that traditional VCs despise. That project is currently down 90% from its ICO price. Chemistry Ventures would never touch a deal like that. And that's exactly the point. The capital they manage goes to companies like Stripe, Plaid, and Klarna—businesses with real unit economics, real users, and real regulatory compliance. Crypto projects need to prove they can achieve the same, or they will continue to lose the funding war. The takeaway is not doom and gloom. It's a wake-up call. The next bull run in crypto will be powered not by VC money, but by actual utility. Projects that solve real problems—like cross-border payments, decentralized identity, or supply chain tracking—will attract capital from fintech-inclined VCs once they prove their model. But that requires a fundamental shift in how crypto founders think about value creation. They need to stop optimizing for token price and start optimizing for user retention. They need to stop chasing 'community' and start chasing product-market fit. I've been in this industry long enough to know that cycles repeat, but the survivors are the ones who adapt. Here's what I'm watching next. First, the flow of capital into crypto-native venture funds like Pantera and Multicoin. If they start raising smaller funds or struggling to close, the signal will be unmistakable. Second, the regulatory landscape: a clear framework for stablecoins or DeFi could flip the script overnight. Third, the emergence of profitable crypto startups—ones that file real financial statements and pay taxes. Those will be the canaries in the coal mine. The tape doesn't lie, and right now it's telling us that the music is changing. The question isn't whether crypto will survive. It's whether it will grow up. I'll leave you with a rhetorical question that's been haunting my Twitter feed: When the next wave of VCs finally returns to crypto, will they find something worth investing in, or just more promises?

Chemistry Ventures' $500M Bet on Fintech Over Crypto: The Capital Shift Nobody Wants to Talk About

Chemistry Ventures' $500M Bet on Fintech Over Crypto: The Capital Shift Nobody Wants to Talk About

Fear & Greed

25

Extreme Fear

Market Sentiment

Altseason Index

44

Bitcoin Season

BTC Dominance Altseason

Market Cap

All →
# Coin Price
1
Bitcoin BTC
$64,088.2
1
Ethereum ETH
$1,843.97
1
Solana SOL
$74.91
1
BNB Chain BNB
$570.1
1
XRP Ledger XRP
$1.09
1
Dogecoin DOGE
$0.0722
1
Cardano ADA
$0.1645
1
Avalanche AVAX
$6.56
1
Polkadot DOT
$0.8325
1
Chainlink LINK
$8.27

🐋 Whale Tracker

🟢
0x6747...c755
1d ago
In
394,907 DOGE
🔵
0xe72c...6299
1d ago
Stake
4,022.47 BTC
🔵
0x9bfc...1a0c
3h ago
Stake
3,829.08 BTC